Use of Inhaled Corticosteroids and Healthcare Costs in Mild Persistent Asthma

By Colice Gene   Wu Eric Q.   Birnbaum Howard   Daher Maham   Maryna B. Marynchenko  

Journal of Asthma, Vol. 44, Iss. 6, 2007-07 ,pp. : 479-483

Informa Healthcare

Access to resources Recommend Favorite

Effects of Low-Dose Fluticasone Propionate/Salmeterol Combination Therapy on Exhaled Nitric Oxide and Nitrite/Nitrate in Breath Condensates from Patients with Mild Persistent Asthma

By Pasha M. Asghar   Smith Thomas C.   Feustel Paul J.   Jourd’heuil David  

Journal of Asthma, Vol. 50, Iss. 1, 2013-02 ,pp. : 64-70

Informa Healthcare

Access to resources Recommend Favorite

Asthma Severity in Patients Initiating Controller Monotherapy versus Combination Therapy

By Diette Gregory B.   Fuhlbrigge Anne L.   Allen-Ramey Felicia   Hopper April   Sajjan Shiva G.   Markson Leona E.  

Journal of Asthma, Vol. 48, Iss. 3, 2011-04 ,pp. : 304-310

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Corticosteroids Should Be Initiated Before Discharge from the Emergency Department in Patients with Persistent Asthma

By Self Timothy H.   Twilla Jennifer D.   Rogers Maegan L.   Rumbak Mark J.  

Journal of Asthma, Vol. 46, Iss. 10, 2009-12 ,pp. : 974-979

Informa Healthcare

Access to resources Recommend Favorite

Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder

By Hagiwara May  

Journal of Asthma, Vol. 50, Iss. 3, 2013-04 ,pp. : 287-295

Informa Healthcare

Access to resources Recommend Favorite